PL3679025T3 - Podstawione imidazochinoliny jako agoniści tlr7 - Google Patents
Podstawione imidazochinoliny jako agoniści tlr7Info
- Publication number
- PL3679025T3 PL3679025T3 PL18769603T PL18769603T PL3679025T3 PL 3679025 T3 PL3679025 T3 PL 3679025T3 PL 18769603 T PL18769603 T PL 18769603T PL 18769603 T PL18769603 T PL 18769603T PL 3679025 T3 PL3679025 T3 PL 3679025T3
- Authority
- PL
- Poland
- Prior art keywords
- tlr7 agonists
- substituted imidazoquinolines
- imidazoquinolines
- substituted
- tlr7
- Prior art date
Links
- 229940044616 toll-like receptor 7 agonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2017072353 | 2017-09-06 | ||
| EP18769603.4A EP3679025B8 (en) | 2017-09-06 | 2018-08-31 | Substituted imidazoquinolines as agonists of tlr7 |
| PCT/EP2018/073485 WO2019048353A1 (en) | 2017-09-06 | 2018-08-31 | SUBSTITUTED IMIDAZOQUINOLINES AS TLR7 AGONISTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3679025T3 true PL3679025T3 (pl) | 2022-07-11 |
Family
ID=63586658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18769603T PL3679025T3 (pl) | 2017-09-06 | 2018-08-31 | Podstawione imidazochinoliny jako agoniści tlr7 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US11279684B2 (pl) |
| EP (2) | EP3679025B8 (pl) |
| JP (1) | JP7304848B2 (pl) |
| KR (1) | KR20200050964A (pl) |
| CN (1) | CN111132969B (pl) |
| AU (1) | AU2018329152B2 (pl) |
| BR (1) | BR112020004505A2 (pl) |
| CA (1) | CA3074611A1 (pl) |
| CY (1) | CY1125206T1 (pl) |
| DK (1) | DK3679025T3 (pl) |
| ES (1) | ES2914800T3 (pl) |
| HR (1) | HRP20220669T1 (pl) |
| HU (1) | HUE058995T2 (pl) |
| IL (1) | IL273039B2 (pl) |
| LT (1) | LT3679025T (pl) |
| MX (1) | MX2020002366A (pl) |
| PL (1) | PL3679025T3 (pl) |
| PT (1) | PT3679025T (pl) |
| RS (1) | RS63265B1 (pl) |
| SG (1) | SG11202001926QA (pl) |
| SI (1) | SI3679025T1 (pl) |
| SM (1) | SMT202200226T1 (pl) |
| WO (1) | WO2019048353A1 (pl) |
| ZA (2) | ZA202001267B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019040491A1 (en) * | 2017-08-22 | 2019-02-28 | Dynavax Technologies Corporation | MODIFIED ALKYL CHAIN IMIDAZOQUINOLINE TLR7 / 8 AGONIST COMPOUNDS AND USES THEREOF |
| WO2019048036A1 (en) * | 2017-09-06 | 2019-03-14 | Biontech Ag | SUBSTITUTED IMIDAZOQUINOLINES |
| MX2021010669A (es) * | 2019-03-07 | 2021-09-28 | BioNTech SE | Proceso para la preparacion de una imidazoquinolina sustituida. |
| CA3184740A1 (en) * | 2020-07-08 | 2022-01-13 | Purdue Research Foundation | Compounds, compositions, and methods for the treatment of fibrotic diseases and cancer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6756382B2 (en) | 1999-06-10 | 2004-06-29 | 3M Innovative Properties Company | Amide substituted imidazoquinolines |
| US6451810B1 (en) | 1999-06-10 | 2002-09-17 | 3M Innovative Properties Company | Amide substituted imidazoquinolines |
| US6573273B1 (en) | 1999-06-10 | 2003-06-03 | 3M Innovative Properties Company | Urea substituted imidazoquinolines |
| US6677349B1 (en) | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| MY157827A (en) | 2003-06-27 | 2016-07-29 | 3M Innovative Properties Co | Sulfonamide substituted imidazoquinolines |
| US8778963B2 (en) | 2003-11-25 | 2014-07-15 | 3M Innovative Properties Company | Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| UA105764C2 (uk) | 2008-03-24 | 2014-06-25 | 4 Сц Аг | Заміщені імідазохіноліни |
| CN108026092B (zh) | 2015-08-31 | 2021-01-26 | 3M创新有限公司 | 胍取代的咪唑并[4,5-c]环化合物 |
| WO2019048036A1 (en) * | 2017-09-06 | 2019-03-14 | Biontech Ag | SUBSTITUTED IMIDAZOQUINOLINES |
-
2018
- 2018-08-31 LT LTEPPCT/EP2018/073485T patent/LT3679025T/lt unknown
- 2018-08-31 MX MX2020002366A patent/MX2020002366A/es unknown
- 2018-08-31 CA CA3074611A patent/CA3074611A1/en active Pending
- 2018-08-31 WO PCT/EP2018/073485 patent/WO2019048353A1/en not_active Ceased
- 2018-08-31 HR HRP20220669TT patent/HRP20220669T1/hr unknown
- 2018-08-31 CN CN201880057607.XA patent/CN111132969B/zh not_active Expired - Fee Related
- 2018-08-31 PT PT187696034T patent/PT3679025T/pt unknown
- 2018-08-31 HU HUE18769603A patent/HUE058995T2/hu unknown
- 2018-08-31 AU AU2018329152A patent/AU2018329152B2/en not_active Ceased
- 2018-08-31 ES ES18769603T patent/ES2914800T3/es active Active
- 2018-08-31 DK DK18769603.4T patent/DK3679025T3/da active
- 2018-08-31 EP EP18769603.4A patent/EP3679025B8/en active Active
- 2018-08-31 RS RS20220493A patent/RS63265B1/sr unknown
- 2018-08-31 JP JP2020513788A patent/JP7304848B2/ja active Active
- 2018-08-31 BR BR112020004505-5A patent/BR112020004505A2/pt not_active Application Discontinuation
- 2018-08-31 US US16/644,079 patent/US11279684B2/en active Active
- 2018-08-31 SG SG11202001926QA patent/SG11202001926QA/en unknown
- 2018-08-31 PL PL18769603T patent/PL3679025T3/pl unknown
- 2018-08-31 SM SM20220226T patent/SMT202200226T1/it unknown
- 2018-08-31 SI SI201830679T patent/SI3679025T1/sl unknown
- 2018-08-31 IL IL273039A patent/IL273039B2/en unknown
- 2018-08-31 EP EP22169256.9A patent/EP4098652A1/en not_active Withdrawn
- 2018-08-31 KR KR1020207006141A patent/KR20200050964A/ko not_active Ceased
-
2020
- 2020-02-27 ZA ZA2020/01267A patent/ZA202001267B/en unknown
-
2021
- 2021-02-26 ZA ZA2021/01323A patent/ZA202101323B/en unknown
-
2022
- 2022-02-10 US US17/669,117 patent/US11987569B2/en active Active
- 2022-05-27 CY CY20221100368T patent/CY1125206T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3687999T (pt) | Derivados de rapamicina | |
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| LT3190113T (lt) | Pirolopirimidino junginiai, naudotini kaip tlr7 agonistai | |
| DK3642202T3 (da) | Dihydro-pyrrolo-pyridin-derivater | |
| EP3337481A4 (en) | HUMAN TLR8 SELECTIVE AGONISTS | |
| MA41976A (fr) | Composition lubrifiante ultra-fluide | |
| BR112017006622A2 (pt) | derivados de ácido borônico | |
| HUE067529T2 (hu) | Berendezés tárgyak megvilágítására | |
| EP3385358A4 (en) | LUBRICANT COMPOSITION | |
| HUE057043T2 (hu) | Kinolin-2-on származékok | |
| FR3034100B1 (fr) | Composition lubrifiante | |
| EP3409751A4 (en) | LUBRICANT COMPOSITION | |
| LT3371168T (lt) | Indolin-2-ono dariniai | |
| MA41790A (fr) | Dérivé de morphinane | |
| EP3309163A4 (en) | SUBSTITUTED DIHYDROPYRROLO PYRAZOL DERIVATIVE | |
| EP4488349B1 (en) | AZOLE DERIVATIVES USED AS LUBRICANT ADDITIVES | |
| ZA202101323B (en) | Substituted imidazoquinolines as agonists of tlr7 | |
| EP3492568A4 (en) | LUBRICANT COMPOSITION | |
| DK3679038T3 (da) | Substituerede imidazoquinoliner | |
| PT3801538T (pt) | Agonistas de tlr7 | |
| DK3672977T3 (da) | Boronsyrederivater | |
| DK3645513T3 (da) | Benzazepinderivater | |
| EP3440070C0 (en) | 8-HYDROXY-QUINOLINE DERIVATIVES REVERSING MULTIDRUG RESISTANCE | |
| EP3344737C0 (en) | LUBRICATING COMPOSITION | |
| PL3645539T3 (pl) | Pochodne pirydoimidazoryfamycyny jako środek przeciwbakteryjny |